FDA Inspection 1320234 — Marjo S. van der Knaap, MD, PhD
The FDA completed an inspection of Marjo S. van der Knaap, MD, PhD on May 15, 2026 in Amsterdam. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 15, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Amsterdam (Netherlands)
Additional Details
Clinical Investigator (CI)